Ms Stephanie Hebert, | |
5940 Sam Fellow Rd, Smithfield, UT 84335-9643 | |
(435) 757-8584 | |
Not Available |
Full Name | Ms Stephanie Hebert |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 5940 Sam Fellow Rd, Smithfield, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841501772 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
Entity Name | Family Health Services Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033165550 PECOS PAC ID: 7012815038 Enrollment ID: O20040216000531 |
News Archive
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
An international research group has clarified the action mechanism of incretin-based drugs in the treatment of diabetes.
Evidence for the efficacy of in-hospital strategies to improve patient safety culture are lacking, show the results of a systematic review.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Stephanie Hebert, 5940 Sam Fellow Rd, Smithfield, UT 84335-9643 Ph: (435) 757-8584 | Ms Stephanie Hebert, 5940 Sam Fellow Rd, Smithfield, UT 84335-9643 Ph: (435) 757-8584 |
News Archive
"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
An international research group has clarified the action mechanism of incretin-based drugs in the treatment of diabetes.
Evidence for the efficacy of in-hospital strategies to improve patient safety culture are lacking, show the results of a systematic review.
› Verified 7 days ago
Dr. Bryan David Ramboz, PH.D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 867 E 450 S, Smithfield, UT 84335 Phone: 435-754-4697 |